{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:44:46Z","timestamp":1781916286961,"version":"3.54.5"},"reference-count":60,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:p>The 2022 outbreak of monkeypox is of worldwide significance. There has been a rapid escalation in case numbers despite efforts to contain it and the WHO has declared it a Public Health Emergency of International Concern. To date, over 51 257 laboratory-confirmed cases have been reported, the majority in non-endemic countries, with 3279 in the UK. It is vital for ophthalmologists to understand this disease and the risk it poses.<\/jats:p><jats:p><jats:named-content content-type=\"indent\">\u2003<\/jats:named-content>Human monkeypox is a zoonotic disease caused by the monkeypox virus, a double-stranded DNA virus in the<jats:italic>Orthopoxvirus<\/jats:italic>genus of the<jats:italic>Poxviridae<\/jats:italic>family. Other orthopoxviruses include variola (smallpox), cowpox and vaccinia; all of which have significant ocular sequelae. Transmission occurs from an animal reservoir (unknown, likely rodents) to a human host, leading to secondary human-to-human spread. During the recent outbreak, a higher incidence has been found in gay, bisexual or other men who have sex with men.<\/jats:p><jats:p><jats:named-content content-type=\"indent\">\u2003<\/jats:named-content>Clinical diagnosis may be challenging as presentation can mimic common ophthalmic diseases. A thorough history is key to identifying potential cases. Ophthalmic manifestations may include preseptal cellulitis, conjunctivitis and keratitis. The oral antiviral agent tecovirimat, which was developed to treat smallpox, is the mainstay of treatment. Trifluorothymidine (trifluridine) eye-drops can be used for ophthalmic involvement. In addition, smallpox vaccines have provided some cross-immunity.<\/jats:p><jats:p><jats:named-content content-type=\"indent\">\u2003<\/jats:named-content>Ocular monkeypox should be managed by infectious diseases specialists, in consultation with ophthalmologists to provide the expertise needed to treat potentially vision-threatening complications. This outbreak highlights the need for healthcare providers to implement appropriate infection control measures and be familiar with the identification and treatment of both cutaneous and ocular disease.<\/jats:p>","DOI":"10.1136\/bjo-2022-322268","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T17:21:43Z","timestamp":1665422503000},"page":"1629-1634","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":25,"title":["Monkeypox as an emerging infectious disease: the ophthalmic implications"],"prefix":"10.1136","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9196-9647","authenticated-orcid":false,"given":"Alice L","family":"Milligan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-yin","family":"Koay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Dunning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"2023030623100858000_106.12.1629.1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fpubh.2018.00241","article-title":"Emergence of monkeypox as the most important orthopoxvirus infection in humans","volume":"6","author":"Sklenovsk\u00e1","year":"2018","journal-title":"Front Public Health"},{"key":"2023030623100858000_106.12.1629.2","unstructured":"Centers for Disease Control and Prevention (CDC) . 2022 monkeypox outbreak global MAP, 2022. Available: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/response\/2022\/world-map.html [Accessed 1 Sep 2022]."},{"key":"2023030623100858000_106.12.1629.3","unstructured":"World Health Organisation (WHO) . Multi-country monkeypox outbreak: situation update. Available: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2022-DON392 [Accessed 28 Jun 2022]."},{"key":"2023030623100858000_106.12.1629.4","unstructured":"UKHSA . Investigation into monkeypox outbreak in England: technical briefing 1 - GOV.UK, 2022. Available: https:\/\/www.gov.uk\/government\/publications\/monkeypox-outbreak-technical-briefings\/investigation-into-monkeypox-outbreak-in-england-technical-briefing-1 [Accessed 29 Jun 2022]."},{"key":"2023030623100858000_106.12.1629.5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jinf.2022.05.028","article-title":"Transmission of monkeypox virus through sexual contact - A novel route of infection","volume":"85","author":"Heskin","year":"2022","journal-title":"J Infect"},{"key":"2023030623100858000_106.12.1629.6","unstructured":"Bennett J , Dolin R , Blaser M . Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases, 2019."},{"key":"2023030623100858000_106.12.1629.7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit703"},{"key":"2023030623100858000_106.12.1629.8","first-page":"156","article-title":"A POX\u2010LIKE disease in cynomolgus monkeys","volume":"46","author":"von","year":"1959","journal-title":"APMIS"},{"key":"2023030623100858000_106.12.1629.9","unstructured":"Ladnyj ID , Ziegler P , Kima E . A human infection caused by monkeypox virus in Basankusu Territory. Democratic Republic of the Congo, 1972."},{"key":"2023030623100858000_106.12.1629.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032299"},{"key":"2023030623100858000_106.12.1629.11","unstructured":"Centers for Disease Control and Prevention (CDC) . Update: Multistate Outbreak of Monkeypox - Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. Available: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5227a5.htm [Accessed 28 Jun 2022]."},{"key":"2023030623100858000_106.12.1629.12","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2005.73.428"},{"key":"2023030623100858000_106.12.1629.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.04.062"},{"key":"2023030623100858000_106.12.1629.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2018.11.008"},{"key":"2023030623100858000_106.12.1629.15","unstructured":"World Health Organisation (WHO) . Monkeypox: experts give virus variants new names. news release, 2022. Available: https:\/\/www.who.int\/news\/item\/12-08-2022-monkeypox-experts-give-virus-variants-new-names [Accessed 22 Aug 2022]."},{"key":"2023030623100858000_106.12.1629.16","unstructured":"World Health Organisation (WHO) . Clinical management and infection prevention and control for monkeypox: interim rapid response guidance, 2022. Available: https:\/\/www.who.int\/publications\/i\/item\/WHO-MPX-Clinical-and-IPC-2022.1 [Accessed 28 Jun 2022]."},{"key":"2023030623100858000_106.12.1629.17","first-page":"459","article-title":"Clinico-epidemiological features of monkeypox patients with an animal or human source of infection","volume":"66","author":"Jezek","year":"1988","journal-title":"Bull World Health Organ"},{"key":"2023030623100858000_106.12.1629.18","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2023030623100858000_106.12.1629.19","doi-asserted-by":"crossref","unstructured":"Beer EM , Rao VB . A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis 2019;13:e0007791.doi:10.1371\/journal.pntd.0007791","DOI":"10.1371\/journal.pntd.0007791"},{"key":"2023030623100858000_106.12.1629.20","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30294-4"},{"key":"2023030623100858000_106.12.1629.21","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/infdis\/jix260","article-title":"Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo","volume":"216","author":"Mbala","year":"2017","journal-title":"J Infect Dis"},{"key":"2023030623100858000_106.12.1629.22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/lam.12126","article-title":"Environmental persistence of vaccinia virus on materials","volume":"57","author":"Wood","year":"2013","journal-title":"Lett Appl Microbiol"},{"key":"2023030623100858000_106.12.1629.23","unstructured":"World Health Organisation (WHO) . Update 77 \u2013 monkeypox outbreak, update and advice for health workers. Available: https:\/\/www.who.int\/publications\/m\/item\/update-77-monkeypox-outbreak [Accessed 28 Jun 2022]."},{"key":"2023030623100858000_106.12.1629.24","unstructured":"Public Health England (PHE) . Monkeypox: information for primary care, 2019. Available: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/850059\/Monkeypox_information_for_primary_care.pdf [Accessed 28 Jun 2022]."},{"key":"2023030623100858000_106.12.1629.25","unstructured":"UKHSA . Monkeypox: semen testing for viral DNA, 2022. Available: https:\/\/www.gov.uk\/guidance\/monkeypox-semen-testing-for-viral-dna [Accessed 23 Aug 2022]."},{"key":"2023030623100858000_106.12.1629.26","unstructured":"World Health Organisation (WHO) . Monkeypox key facts. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/monkeypox [Accessed 29 Jun 2022]."},{"key":"2023030623100858000_106.12.1629.27","doi-asserted-by":"publisher","DOI":"10.1086\/505880"},{"key":"2023030623100858000_106.12.1629.28","unstructured":"Nigeria Centre for Disease Control (NCDC) . Monkeypox public health response guidelines, 2019. Available: https:\/\/ncdc.gov.ng\/themes\/common\/docs\/protocols\/96_1577798337.pdf [Accessed 29 Jun 2022]."},{"key":"2023030623100858000_106.12.1629.29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijid.2014.03.994","article-title":"Ocular complications associated with acute monkeypox virus infection, DRC","volume":"21","author":"Hughes","year":"2014","journal-title":"International Journal of Infectious Diseases"},{"key":"2023030623100858000_106.12.1629.30","doi-asserted-by":"crossref","unstructured":"Reynolds M , McCollum A , Nguete B , et al . Improving the care and treatment of monkeypox patients in low-resource settings: applying evidence from contemporary biomedical and smallpox Biodefense research. Viruses 2017;9:380.doi:10.3390\/v9120380","DOI":"10.3390\/v9120380"},{"key":"2023030623100858000_106.12.1629.31","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/156.2.293"},{"key":"2023030623100858000_106.12.1629.32","doi-asserted-by":"crossref","unstructured":"Semba RD . The ocular complications of smallpox and smallpox immunization. Arch Ophthal 2003;121:715.doi:10.1001\/archopht.121.5.715","DOI":"10.1001\/archopht.121.5.715"},{"key":"2023030623100858000_106.12.1629.33","first-page":"523","article-title":"Virus excretion in smallpox. 2. excretion in the throats of household contacts","volume":"48","author":"Sarkar","year":"1973","journal-title":"Bull World Health Organ"},{"key":"2023030623100858000_106.12.1629.34","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq103"},{"key":"2023030623100858000_106.12.1629.35","doi-asserted-by":"crossref","unstructured":"Ruben FL . Ocular vaccinia. Arch Ophthal 1970;84:45.doi:10.1001\/archopht.1970.00990040047012","DOI":"10.1001\/archopht.1970.00990040047012"},{"key":"2023030623100858000_106.12.1629.36","unstructured":"Centers for Disease Control and Prevention (CDC) . Smallpox vaccination and adverse reactions. Available: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5204a1.htm [Accessed 28 Jun 2022]."},{"key":"2023030623100858000_106.12.1629.37","doi-asserted-by":"publisher","DOI":"10.3201\/eid2112.150621"},{"key":"2023030623100858000_106.12.1629.38","doi-asserted-by":"crossref","unstructured":"Graef S , Kurth A , Auw-Haedrich C , et al . Clinicopathological findings in persistent corneal cowpox infection. JAMA Ophthalmol 2013;131:1089.doi:10.1001\/jamaophthalmol.2013.264","DOI":"10.1001\/jamaophthalmol.2013.264"},{"key":"2023030623100858000_106.12.1629.39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb04969.x"},{"key":"2023030623100858000_106.12.1629.40","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMicm2033620","article-title":"Orbital cowpox","volume":"384","author":"Kiernan","year":"2021","journal-title":"N Engl J Med"},{"key":"2023030623100858000_106.12.1629.41","unstructured":"UKHSA . Monkeypox: case definitions - GOV.UK, 2022. Available: https:\/\/www.gov.uk\/guidance\/monkeypox-case-definitions [Accessed 22 Aug 2022]."},{"key":"2023030623100858000_106.12.1629.42","unstructured":"World Health Organisation (WHO) . Laboratory testing for the monkeypox virus: interim guidance. Available: https:\/\/www.who.int\/publications\/i\/item\/WHO-MPX-laboratory-2022.1 [Accessed 29 Jun 2022]."},{"key":"2023030623100858000_106.12.1629.43","unstructured":"UK Health Security Agency . Principles for monkeypox control in the UK: 4 nations consensus statement - GOV.UK. Available: https:\/\/www.gov.uk\/government\/publications\/principles-for-monkeypox-control-in-the-uk-4-nations-consensus-statement\/principles-for-monkeypox-control-in-the-uk-4-nations-consensus-statement [Accessed 28 Jun 2022]."},{"key":"2023030623100858000_106.12.1629.44","unstructured":"European Medicines Agency (EMA) . Tecovirimat sIgA | European medicines Agency. Available: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/tecovirimat-siga#authorisation-details-section [Accessed 28 Jun 2022]."},{"key":"2023030623100858000_106.12.1629.45","doi-asserted-by":"crossref","first-page":"943","DOI":"10.15585\/mmwr.mm6842a2","article-title":"Novel Treatment of a Vaccinia Virus Infection from an Occupational Needlestick - San Diego, California, 2019","volume":"68","author":"Whitehouse","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023030623100858000_106.12.1629.46","unstructured":"SIGA . Siga technologies receives approval from UK for Tecovirimat, 2022. Available: https:\/\/investor.siga.com\/news-releases\/news-release-details\/siga-technologies-receives-approval-uk-tecovirimat [Accessed 13 Jul 2022]."},{"key":"2023030623100858000_106.12.1629.47","unstructured":"University of Oxford . Platinum: placebo-controlled randomised trial of tecovirimat in non-hospitalised monkeypox patients, 2022. Available: https:\/\/platinumtrial.ox.ac.uk\/ [Accessed 23 Aug 2022]."},{"key":"2023030623100858000_106.12.1629.48","unstructured":"WHO Clinical Expert Group . Core protocol: a randomized, placebo-controlled, double-blinded trial of the safety and efficacy of treatments for patients with monkeypox virus disease, 2022. Available: https:\/\/www.who.int\/tools\/global-clinical- [Accessed 13 Jul 2022]."},{"key":"2023030623100858000_106.12.1629.49","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(98)94019-2"},{"key":"2023030623100858000_106.12.1629.50","doi-asserted-by":"publisher","DOI":"10.3390\/v2122803"},{"key":"2023030623100858000_106.12.1629.51","unstructured":"National Library of Medicine . Trifluridine | C10H11F3N2O5 - PubChem. Available: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Trifluridine [Accessed 28 Jun 2022]."},{"key":"2023030623100858000_106.12.1629.52","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7205\/MILMED-D-10-00473","article-title":"Ocular vaccinia: a consequence of unrecognized contact transmission","volume":"176","author":"Montgomery","year":"2011","journal-title":"Mil Med"},{"key":"2023030623100858000_106.12.1629.53","unstructured":"Pfizer . VIROPTIC \u00ae Ophthalmic Solution, 1% Sterile (trifluridine ophthalmic solution) product overview."},{"key":"2023030623100858000_106.12.1629.54","unstructured":"British National Formulary (BNF) . Eye | treatment summaries | BNF | NICE. Available: https:\/\/bnf.nice.org.uk\/treatment-summaries\/eye\/#ophthalmic-specials [Accessed 30 Jun 2022]."},{"key":"2023030623100858000_106.12.1629.55","unstructured":"UK Health Security Agency . Green book chapter 29 smallpox and monkeypox. Available: https:\/\/webarchive.nationalarchives.gov.uk\/ukgwa\/20130107105354\/http:\/\/www.dh.gov.uk\/ [Accessed 28 Jun 2022]."},{"key":"2023030623100858000_106.12.1629.56","unstructured":"UKHSA . Recommendations for the use of pre and post exposure vaccination during a monkeypox incident, 2022. Available: https:\/\/www.gov.uk\/government\/publications\/monkeypox-vaccination [Accessed 28 Jun 2022]."},{"key":"2023030623100858000_106.12.1629.57","unstructured":"UKHSA . HCID status of monkeypox, 2022. Available: https:\/\/www.gov.uk\/guidance\/hcid-status-of-monkeypox [Accessed 13 Jul 2022]."},{"key":"2023030623100858000_106.12.1629.58","unstructured":"UKHSA . De-isolation and discharge of monkeypox-infected patients: interim guidance, 2022. Available: https:\/\/www.gov.uk\/guidance\/de-isolation-and-discharge-of-monkeypox-infected-patients-interim-guidance [Accessed 13 Jul 2022]."},{"key":"2023030623100858000_106.12.1629.59","unstructured":"UKHSA . Monkeypox: people who are isolating at home, 2022. Available: https:\/\/www.gov.uk\/guidance\/guidance-for-people-with-monkeypox-infection-who-are-isolating-at-home [Accessed 23 Aug 2022]."},{"key":"2023030623100858000_106.12.1629.60","unstructured":"UKHSA . Virtual management of confirmed monkeypox cases, 2022. Available: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2022\/06\/B1692-virtual-management-of-confirmed-monkeypox-cases.pdf [Accessed 23 Aug 2022]."}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2022-322268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T07:11:37Z","timestamp":1678173097000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2022-322268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":60,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,11,22]]},"published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1136\/bjo-2022-322268"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2022-322268","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]}}}